Marketing-authorisation holder · United States
Barr
41 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · United States
41 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 41
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ARANELLE0.035mg,0.035mg,0.035mg; 0.5mg,1mg,0.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2004 |
| BALZIVA-210.035mg; 0.4mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2004 |
| BALZIVA-280.035mg; 0.4mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2004 |
| DANAZOL100mg | 200mg | 50mg · Capsule | Danazol | United States | Marketed | 1996 |
| DIPYRIDAMOLE25mg | 50mg | 75mg · Tablet | Dipyridamole | United States | Marketed | 1980 |
| E-BASE333mg | 500mg · Tablet, delayed release | Erythromycin | United States | Not marketed | 1988 |
| ERYTHROMYCIN ETHYLSUCCINATE400mg base · Tablet | Erythromycin | United States | Marketed | 1975 |
| ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL200mg base/5ml; 600mg base/5ml · Granule | Erythromycin, Sulfisoxazole acetyl | United States | Not marketed | 1988 |
| ESTRADIOL AND NORGESTIMATE1mg,1mg; 0.09mg · Tablet | Estradiol, Norgestimate n/a,0.09mg | United States | Not marketed | 2005 |
| ETHAMBUTOL HYDROCHLORIDE100mg | 400mg · Tablet | Ethambutol | United States | Marketed | 1999 |
| FEXOFENADINE HYDROCHLORIDE60mg · Capsule | Fexofenadine | United States | Not marketed | 2005 |
| GENCEPT 10/11-210.035mg,0.035mg; 0.5mg,1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1992 |
| GRANISETRON HYDROCHLORIDE1mg base · Tablet | Granisetron | United States | Marketed | 2007 |
| HYDROMORPHONE HYDROCHLORIDE0.25mg/0.5ml | 0.2mg/ml | 0.5mg/0.5ml | 10mg/ml | 1mg/ml | 2mg/ml | 4mg/ml · Injectable | Hydromorphone | United States | Marketed | 1995 |
| HYDROXYUREA1GM · Tablet | Hydroxycarbamide | United States | Not marketed | 2000 |
| JUNEL 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2003 |
| JUNEL FE 1/200.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2003 |
| JUNEL FE 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2003 |
| KARIVA0.15mg,n/a; 0.02mg,0.01mg · Tablet | Desogestrel, N/a, Ethinyl estradiol | United States | Marketed | 2002 |
| KELNOR0.035mg; 1mg · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Marketed | 2005 |
| LESSINA-210.02mg; 0.1mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Not marketed | 2002 |
| LESSINA-280.02mg; 0.1mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2002 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL0.02mg; 0.1mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Not marketed | 2003 |
| MEGESTROL ACETATE20mg | 40mg · Tablet | Megestrol | United States | Marketed | 1988 |
| NORTREL 0.5/35-210.035mg; 0.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1992 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 41 | 41 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.